Literature DB >> 11738129

Localization of cGMP-dependent protein kinase type II in rat brain.

J de Vente1, E Asan, S Gambaryan, M Markerink-van Ittersum, H Axer, K Gallatz, S M Lohmann, M Palkovits.   

Abstract

In brain, signaling pathways initiated by atrial natriuretic peptide, or transmitters which stimulate nitric oxide synthesis, increase cGMP as their second messenger. One important class of target molecules for cGMP is cGMP-dependent protein kinases, and in the present study, biochemical and immunocytochemical analyses demonstrate the widespread distribution of type II cGMP-dependent protein kinase in rat brain, from the cerebral cortex to the brainstem and cerebellum. Also, colocalization of cGMP-dependent protein kinase type II with its activator, cGMP, was found in several brain regions examined after in vitro stimulation of brain slices with sodium nitroprusside. In western blots, cGMP-dependent protein kinase type II was observed in all brain regions examined, although cerebellar cortex and pituitary contained comparatively less of the kinase. Immunocytochemistry revealed cGMP-dependent protein kinase type II in certain neurons, and occasionally in putative oligodendrocytes and astrocytes, however, its most striking and predominant localization was in neuropil. Electron microscopy examination of neuropil in the medial habenula showed localization of the kinase in both axon terminals and dendrites. As a membrane-associated protein, cGMP-dependent protein kinase type II often appeared to be transported to cell processes to a greater extent than being retained in the cell body. Thus, immunocytochemical labeling of cGMP-dependent protein kinase type II often did not coincide with the localization of kinase mRNA previously observed by others using in situ hybridization. We conclude that in contrast to cGMP-dependent protein kinase type I, which has a very restricted localization to cerebellar Purkinje cells and a few other sites, cGMP-dependent protein kinase type II is a very ubiquitous brain protein kinase and thus a more likely candidate for relaying myriad cGMP effects in brain requiring protein phosphorylation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11738129     DOI: 10.1016/s0306-4522(01)00401-8

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  22 in total

1.  Myristoylation of cGMP-dependent protein kinase dictates isoform specificity for serotonin transporter regulation.

Authors:  Yuan-Wei Zhang; Gary Rudnick
Journal:  J Biol Chem       Date:  2010-11-19       Impact factor: 5.157

2.  cGMP-dependent protein kinase I in vascular smooth muscle cells improves ischemic stroke outcome in mice.

Authors:  Maria Shvedova; Maxim M Litvak; Jesse D Roberts; Dai Fukumura; Tomoaki Suzuki; İkbal Şencan; Ge Li; Paula Reventun; Emmanuel S Buys; Hyung-Hwan Kim; Sava Sakadžić; Cenk Ayata; Paul L Huang; Robert Feil; Dmitriy N Atochin
Journal:  J Cereb Blood Flow Metab       Date:  2019-08-18       Impact factor: 6.200

Review 3.  Regulation and function of cyclic GMP-mediated pathways in glial cells.

Authors:  María Antonia Baltrons; Mariela Susana Borán; Paula Pifarré; Agustina García
Journal:  Neurochem Res       Date:  2008-04-01       Impact factor: 3.996

4.  The type II cGMP dependent protein kinase regulates GluA1 levels at the plasma membrane of developing cerebellar granule cells.

Authors:  Salvatore Incontro; Francisco Ciruela; Edward Ziff; Franz Hofmann; José Sánchez-Prieto; Magdalena Torres
Journal:  Biochim Biophys Acta       Date:  2013-03-29

Review 5.  NO orchestrates the loss of synaptic boutons from adult "sick" motoneurons: modeling a molecular mechanism.

Authors:  Bernardo Moreno-López; Carmen R Sunico; David González-Forero
Journal:  Mol Neurobiol       Date:  2010-12-29       Impact factor: 5.590

Review 6.  Animal models of dystonia: Lessons from a mutant rat.

Authors:  Mark S LeDoux
Journal:  Neurobiol Dis       Date:  2010-11-21       Impact factor: 5.996

7.  Nitric oxide induces pathological synapse loss by a protein kinase G-, Rho kinase-dependent mechanism preceded by myosin light chain phosphorylation.

Authors:  Carmen R Sunico; David González-Forero; Germán Domínguez; José Manuel García-Verdugo; Bernardo Moreno-López
Journal:  J Neurosci       Date:  2010-01-20       Impact factor: 6.167

8.  Dynamic interactions of excitatory and inhibitory inputs in hypoglossal motoneurones: respiratory phasing and modulation by PKA.

Authors:  Shane A Saywell; Jack L Feldman
Journal:  J Physiol       Date:  2003-12-05       Impact factor: 5.182

9.  Signalling pathway of nitric oxide in synaptic GABA release in the rat paraventricular nucleus.

Authors:  De-Pei Li; Shao-Rui Chen; Thomas F Finnegan; Hui-Lin Pan
Journal:  J Physiol       Date:  2004-01-01       Impact factor: 5.182

10.  Sildenafil accelerates reentrainment of circadian rhythms after advancing light schedules.

Authors:  Patricia V Agostino; Santiago A Plano; Diego A Golombek
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-22       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.